Kura Oncology (KURA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Kura Oncology (KURA) is Neutral.

The composite score behind that read is -0.08, weighing +0.00 of bullish evidence against -0.26 bearish.

Kura Oncology last closed at $10.60, +0.76% on the session.

Against the IVW growth benchmark the position is -0.04% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

17 graded predictions for KURA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Kura Oncology in the 5th percentile on return on equity, where 100 is best.

Kura Oncology is classified under Health Care / Biotechnology, with a market capitalisation of $935.87M.

StockMap tracks Kura Oncology as the 134th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Kura Oncology ranks 203rd of 381 in the group, against a group median of -0.08.